Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Usage Information

The SLC6A14 gene shows evidence of association with obesity
Elina Suviolahti, Laura J. Oksanen, Miina Öhman, Rita M. Cantor, Martin Ridderstråle, Tiinamaija Tuomi, Jaakko Kaprio, Aila Rissanen, Pertti Mustajoki, Pekka Jousilahti, Erkki Vartiainen, Kaisa Silander, Riika Kilpikari, Veikko Salomaa, Leif Groop, Kimmo Kontula, Leena Peltonen, Päivi Pajukanta
Elina Suviolahti, Laura J. Oksanen, Miina Öhman, Rita M. Cantor, Martin Ridderstråle, Tiinamaija Tuomi, Jaakko Kaprio, Aila Rissanen, Pertti Mustajoki, Pekka Jousilahti, Erkki Vartiainen, Kaisa Silander, Riika Kilpikari, Veikko Salomaa, Leif Groop, Kimmo Kontula, Leena Peltonen, Päivi Pajukanta
View: Text | PDF
Article Aging

The SLC6A14 gene shows evidence of association with obesity

  • Text
  • PDF
Abstract

In our previous genome-wide scan of Finnish nuclear families, obesity was linked to chromosome Xq24. Here we analyzed this 15-Mb region by genotyping 9 microsatellite markers and 36 single nucleotide polymorphisms (SNPs) for 11 positional and functional candidate genes in an extended sample of 218 obese Finnish sibling pairs (sibpairs) (BMI > 30 kg/m2). Evidence of linkage emerged mainly from the obese male sibpairs, suggesting a gender-specific effect for the underlying gene. By constructing haplotypes among the obese male sibpairs, we restricted the region from 15 Mb to 4 Mb, between markers DXS8088 and DXS8067. Regional functional candidate genes were tested for association in an initial sample of 117 cases and 182 controls. Significant evidence was observed for association for an SNP in the 3′-untranslated region of the solute carrier family 6 member 14 (SLC6A14) gene (P = 0.0002) and for SNP haplotypes of the SLC6A14 gene (P = 0.0007–0.006). Furthermore, an independent replication study sample of 837 cases and 968 controls from Finland and Sweden also showed significant differences in allele frequencies between obese and non-obese individuals (P = 0.003). The SLC6A14 gene is an interesting novel candidate for obesity because it encodes an amino acid transporter, which potentially regulates tryptophan availability for serotonin synthesis and thus possibly affects appetite control.

Authors

Elina Suviolahti, Laura J. Oksanen, Miina Öhman, Rita M. Cantor, Martin Ridderstråle, Tiinamaija Tuomi, Jaakko Kaprio, Aila Rissanen, Pertti Mustajoki, Pekka Jousilahti, Erkki Vartiainen, Kaisa Silander, Riika Kilpikari, Veikko Salomaa, Leif Groop, Kimmo Kontula, Leena Peltonen, Päivi Pajukanta

×

Usage data is cumulative from May 2025 through May 2026.

Usage JCI PMC
Text version 889 34
PDF 147 18
Figure 140 0
Table 352 0
Citation downloads 78 0
Totals 1,606 52
Total Views 1,658
(Click and drag on plot area to zoom in. Click legend items above to toggle)

Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.

Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.

Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts